What does it take to move from a high school classroom in Sri Lanka to leading a key sequencing team in the historic race to decode the Human Genome?
In a captivating address hosted on the Sri Lanka Science Channel, Prof. Preethi Gunaratne—John and Rebecca Moores Professor at the University of Houston and Director of the University of Houston Sequencing and Gene Editing Core—shared her remarkable journey. Her story is not just a masterclass in modern genomics, single-cell transcriptomics, and personalized cancer vaccines; it is a proud reflection of what Sri Lanka’s free education and public health systems can achieve on the global stage.
A Legacy Rooted in Sri Lankan Education
Prof. Gunaratne’s entry into science was fueled by family legacy and academic discipline. The daughter of two physicists, her path took a definitive turn when her father showed her a 1954 group photograph from the Cavendish Laboratory at Cambridge—a photo taken at the exact time and place where James Watson and Francis Crick discovered the double helix structure of DNA. Inspired to explore the logical, code-like nature of biology, she pursued her Bachelor of Science in Zoology at the University of Colombo before earning her Ph.D. in Genetics at Cornell University.
“My journey from Visakha Vidyalaya and the University of Colombo to leading genomics teams in the U.S. is proof of the power of Sri Lanka’s free education system. It gives young people the foundational strength to compete with the very best in the world.”
Inside the Race for the Human Genome
During her time at the Baylor College of Medicine Human Genome Sequencing Center, Prof. Gunaratne led the cDNA sequencing team during one of the most intense periods in modern scientific history: the $3-billion Human Genome Project (HGP).
When corporate competitors threatened to patent human genetic code, public institutions had to scale overnight. Prof. Gunaratne directed an operation that grew to 250 people running 75 automated sequencers in 24/7 shifts. Her team made the largest single contribution (>15,000 full-length cDNA sequences) to Phase I of the Mammalian Gene Collection, successfully keeping the human genome in the public domain for researchers worldwide.
The Next Frontier: Precision Health & Personalized Vaccines
The technology that once cost $3 billion and took 13 years can now sequence a genome in days for under $400. In her address, Prof. Gunaratne highlighted how this exponential drop in cost has unlocked Precision Medicine and Cancer Immunoprevention:
- Single-Cell Sequencing: Instead of analyzing tissue as a whole, scientists can now read gene expression cell-by-cell to detect precancerous changes long before tumors form.
- Chimeric RNA Fusions & Neoantigens: Non-classical mutations create unique fusion junction peptides that exist only in tumor cells, making them ideal targets with low risk of autoimmunity.
- Personalized Cancer Vaccines: By identifying these tumor-specific neoantigens in individual patients, researchers are developing mRNA and peptide vaccines designed to train the patient’s own immune system to destroy or prevent cancer before it spreads.
Inspiring the Next Generation of Sri Lankan Scientists
Beyond the data and patents, Prof. Gunaratne’s primary message was aimed at Sri Lanka’s next generation of scientists and policymakers. She emphasized that investment in public health and free tertiary education pays massive long-term dividends—producing leaders capable of driving multi-million-dollar global research platforms.
For young Sri Lankans watching, her trajectory offers a clear message: world-class scientific breakthroughs are entirely within reach.
🎥 Watch the Presentation
Experience part of Prof. Preethi Gunaratne’s address on Personalized Vaccines for Cancer Immunoprevention on the Sri Lanka Science Channel:
